| Hospitalization cost as a consequence of underage drinking estimated at $755 million
Researchers used the National Inpatient Sample database to evaluate incidence of hospitalization and outcomes for 40,000 youth ages 15 to 20 hospitalized for alcohol use in 2008. The problem is more prevalent in certain ethnic groups and geographic regions. Regorafenib shown to improve colon cancer survival
Oncologist Axel Grothey, M.D., discusses results of an international phase III clinical trial of the investigative drug regorafenib. A multikinase inhibitor, regorafenib lengthened the lives of metastatic colorectal cancer patients for whom standard therapies were no longer effective. |
Inaugural Individualizing Medicine Conference
Oct. 1-3, 2012, in Rochester, Minn. Explore the promise and challenges of incorporating genomics tools into clinical care. With the rapid pace of discovery and translation, Mayo Clinic hosts this conference to discuss the clinical implications of these emerging technologies and what they mean for the patient. View video on YouTube.
15th Annual Mayo Clinic Internal Medicine Update
Oct. 11-14, 2012, or Oct. 25-28, 2012, in Sedona, Ariz. This four-day course, offered twice in October 2012, provides a practical update on subspecialty topics including allergy, cardiovascular diseases, dermatology, endocrinology, gastroenterology, hematology, infectious diseases, integrative medicine, neurology, psychiatry, pulmonary medicine, renal disease and rheumatology.
Commercial Driver Medical Examiner Training Oct. 28, 2012, or Nov. 11, 2012, in Rochester, Minn.
This one-day course presents core administrative and clinical knowledge for providers who perform physical examinations for interstate CMV drivers. Effective May 21, 2014, providers who issue medical certificates for CMV drivers must complete accredited certification training and be listed on the NRCME.
Mayo Clinic Cancer Center: Thoracic Oncology for the Oncologist Nov. 16-17, 2012, in Phoenix State-of-the-art evaluation and management of thoracic cancers includes recent developments in medical, surgical, radiation and medical oncologic care for patients with malignancies of the chest. A scientific minisymposium focuses on novel developments in molecular pathways of carcinogenesis and immunobiology.
See all Continuous Professional Development courses |
|
David W. Barbara, M.D. Anesthesiology in Minnesota
Stephanie K. Childs, M.D. Radiation Oncology in Minnesota
Tamara J. Dolenc, M.D. Psychiatry and Psychology in Minnesota
Syril K. Dorairaj, M.D. Ophthalmology in Florida
Michael B. Gotway, M.D. Radiology in Arizona
Shahrukh K. Hashmi, M.D. Hematology in Minnesota
Jill M. Huber, M.D. Internal Medicine in Minnesota
Xun Zhu, M.D. Anesthesiology in Minnesota
|